183 related articles for article (PubMed ID: 23160308)
1. The role of lung epithelial ligands for Siglec-8 and Siglec-F in eosinophilic inflammation.
Kiwamoto T; Katoh T; Tiemeyer M; Bochner BS
Curr Opin Allergy Clin Immunol; 2013 Feb; 13(1):106-11. PubMed ID: 23160308
[TBL] [Abstract][Full Text] [Related]
2. Mice deficient in the St3gal3 gene product α2,3 sialyltransferase (ST3Gal-III) exhibit enhanced allergic eosinophilic airway inflammation.
Kiwamoto T; Brummet ME; Wu F; Motari MG; Smith DF; Schnaar RL; Zhu Z; Bochner BS
J Allergy Clin Immunol; 2014 Jan; 133(1):240-7.e1-3. PubMed ID: 23830412
[TBL] [Abstract][Full Text] [Related]
3. Mouse Siglec-F and human Siglec-8 are functionally convergent paralogs that are selectively expressed on eosinophils and recognize 6'-sulfo-sialyl Lewis X as a preferred glycan ligand.
Tateno H; Crocker PR; Paulson JC
Glycobiology; 2005 Nov; 15(11):1125-35. PubMed ID: 15972893
[TBL] [Abstract][Full Text] [Related]
4. Endogenous airway mucins carry glycans that bind Siglec-F and induce eosinophil apoptosis.
Kiwamoto T; Katoh T; Evans CM; Janssen WJ; Brummet ME; Hudson SA; Zhu Z; Tiemeyer M; Bochner BS
J Allergy Clin Immunol; 2015 May; 135(5):1329-1340.e9. PubMed ID: 25497369
[TBL] [Abstract][Full Text] [Related]
5. Siglec-8 on human eosinophils and mast cells, and Siglec-F on murine eosinophils, are functionally related inhibitory receptors.
Bochner BS
Clin Exp Allergy; 2009 Mar; 39(3):317-24. PubMed ID: 19178537
[TBL] [Abstract][Full Text] [Related]
6. Characterization of expression of glycan ligands for Siglec-F in normal mouse lungs.
Guo JP; Brummet ME; Myers AC; Na HJ; Rowland E; Schnaar RL; Zheng T; Zhu Z; Bochner BS
Am J Respir Cell Mol Biol; 2011 Feb; 44(2):238-43. PubMed ID: 20395633
[TBL] [Abstract][Full Text] [Related]
7. Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions.
Kiwamoto T; Kawasaki N; Paulson JC; Bochner BS
Pharmacol Ther; 2012 Sep; 135(3):327-36. PubMed ID: 22749793
[TBL] [Abstract][Full Text] [Related]
8. Sialyltransferase ST3Gal-III regulates Siglec-F ligand formation and eosinophilic lung inflammation in mice.
Suzukawa M; Miller M; Rosenthal P; Cho JY; Doherty TA; Varki A; Broide D
J Immunol; 2013 Jun; 190(12):5939-48. PubMed ID: 23677475
[TBL] [Abstract][Full Text] [Related]
9. Airway glycomic and allergic inflammatory consequences resulting from keratan sulfate galactose 6-O-sulfotransferase (CHST1) deficiency.
Kumagai T; Kiwamoto T; Brummet ME; Wu F; Aoki K; Zhu Z; Bochner BS; Tiemeyer M
Glycobiology; 2018 Jun; 28(6):406-417. PubMed ID: 29659839
[TBL] [Abstract][Full Text] [Related]
10. Eosinophil-selective binding and proapoptotic effect in vitro of a synthetic Siglec-8 ligand, polymeric 6'-sulfated sialyl Lewis x.
Hudson SA; Bovin NV; Schnaar RL; Crocker PR; Bochner BS
J Pharmacol Exp Ther; 2009 Aug; 330(2):608-12. PubMed ID: 19458105
[TBL] [Abstract][Full Text] [Related]
11. Galactose 6-O-sulfotransferases are not required for the generation of Siglec-F ligands in leukocytes or lung tissue.
Patnode ML; Cheng CW; Chou CC; Singer MS; Elin MS; Uchimura K; Crocker PR; Khoo KH; Rosen SD
J Biol Chem; 2013 Sep; 288(37):26533-45. PubMed ID: 23880769
[TBL] [Abstract][Full Text] [Related]
12. Discovery, Function, and Therapeutic Targeting of Siglec-8.
Youngblood BA; Leung J; Falahati R; Williams J; Schanin J; Brock EC; Singh B; Chang AT; O'Sullivan JA; Schleimer RP; Tomasevic N; Bebbington CR; Bochner BS
Cells; 2020 Dec; 10(1):. PubMed ID: 33374255
[TBL] [Abstract][Full Text] [Related]
13. Defining the in vivo function of Siglec-F, a CD33-related Siglec expressed on mouse eosinophils.
Zhang M; Angata T; Cho JY; Miller M; Broide DH; Varki A
Blood; 2007 May; 109(10):4280-7. PubMed ID: 17272508
[TBL] [Abstract][Full Text] [Related]
14. Sialylated keratan sulfate proteoglycans are Siglec-8 ligands in human airways.
Gonzalez-Gil A; Porell RN; Fernandes SM; Wei Y; Yu H; Carroll DJ; McBride R; Paulson JC; Tiemeyer M; Aoki K; Bochner BS; Schnaar RL
Glycobiology; 2018 Oct; 28(10):786-801. PubMed ID: 29924315
[TBL] [Abstract][Full Text] [Related]
15. Siglec-F-dependent negative regulation of allergen-induced eosinophilia depends critically on the experimental model.
McMillan SJ; Richards HE; Crocker PR
Immunol Lett; 2014 Jul; 160(1):11-16. PubMed ID: 24698729
[TBL] [Abstract][Full Text] [Related]
16. Siglec-8 and Siglec-F, the new therapeutic targets in asthma.
Farid SSh; Mirshafiey A; Razavi A
Immunopharmacol Immunotoxicol; 2012 Oct; 34(5):721-6. PubMed ID: 22324980
[TBL] [Abstract][Full Text] [Related]
17. "Siglec"ting the allergic response for therapeutic targeting.
Bochner BS
Glycobiology; 2016 Jun; 26(6):546-52. PubMed ID: 26911285
[TBL] [Abstract][Full Text] [Related]
18. Frontline Science: Characterization of a novel mouse strain expressing human Siglec-8 only on eosinophils.
O'Sullivan JA; Wei Y; Carroll DJ; Moreno-Vinasco L; Cao Y; Zhang F; Lee JJ; Zhu Z; Bochner BS
J Leukoc Biol; 2018 Jul; 104(1):11-19. PubMed ID: 29601103
[TBL] [Abstract][Full Text] [Related]
19. Siglec-8 and Siglec-9 binding specificities and endogenous airway ligand distributions and properties.
Yu H; Gonzalez-Gil A; Wei Y; Fernandes SM; Porell RN; Vajn K; Paulson JC; Nycholat CM; Schnaar RL
Glycobiology; 2017 Jul; 27(7):657-668. PubMed ID: 28369504
[TBL] [Abstract][Full Text] [Related]
20. Chronic OVA allergen challenged Siglec-F deficient mice have increased mucus, remodeling, and epithelial Siglec-F ligands which are up-regulated by IL-4 and IL-13.
Cho JY; Song DJ; Pham A; Rosenthal P; Miller M; Dayan S; Doherty TA; Varki A; Broide DH
Respir Res; 2010 Nov; 11(1):154. PubMed ID: 21040544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
